Rule 424(B)(3)
File No. 333-70523
SUPPLEMENT NO. 1
TO
PROPECTUS DATED DECEMBER 15, 1999
ADVANCED VIRAL RESEARCH CORP.
Information contained in this Supplement No. 1 is intended to update
the information contained in the Prospectus dated December 15, 1999 of Advanced
Viral Research Corp., and is incorporated by reference into such Prospectus. The
following information should be read in conjunction with the Prospectus.
On January 19, 2000, pursuant to notice by RBB Bank Aktiengesellschaft,
the holder of our 7% convertible debenture due October 31, 2008, $1,122,500 of
the principal amount of the debenture was converted into 8,252,746 shares of our
common stock, par value $0.00001.
On January 19, 2000, pursuant to notice by Focus Investors, LLC, the
holder of our 7% convertible debentures due August 3, 2009, $300,000 of the
principal amount of the debentures was converted into 2,178,155 shares of our
common stock.
ADVANCED VIRAL RESEARCH CORP.
The date of this Supplement is January 21, 2000
